e-learning
resources
Amsterdam 2015
Sunday, 27.09.2015
New insights into lung disease pathogenesis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Distinct localization of estrogen receptors in lungs of severe COPD patients
Juanita H.J. Vernooy (Maastricht, Netherlands), Gonda Konings, Niki Reynaert, Andrea Romano, Emiel Wouters, Juanita Vernooy
Source:
International Congress 2015 – New insights into lung disease pathogenesis
Session:
New insights into lung disease pathogenesis
Session type:
Thematic Poster Session
Number:
869
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Juanita H.J. Vernooy (Maastricht, Netherlands), Gonda Konings, Niki Reynaert, Andrea Romano, Emiel Wouters, Juanita Vernooy. Distinct localization of estrogen receptors in lungs of severe COPD patients. Eur Respir J 2015; 46: Suppl. 59, 869
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Increased expression of sphingosine-1-phosphate and S1PR2 are associated with attenuated macrophage phagocytosis in COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Monocyte sub-populations do not reflect differences in COPD macrophage phenotype
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Identification of Ki67+ ’monocytic’ cells within the lungs
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Elevated GM-CSF in COPD may drive defective macrophage phenotype
Source: International Congress 2014 – New insights into monocyte and macrophage biology
Year: 2014
Characterization of M1 and M2 macrophages in human lung tissue
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Altered scavenger receptor expression and response to oxidative stress is linked to defective bacterial phagocytosis in COPD macrophages
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Impaired monocyte chemotaxis in COPD
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
Monocyte-derived macrophages from non-smoker COPD subjects exhibit defective bacterial phagocytosis
Source: International Congress 2015 – Mucosal immunology: what’s new in 2015
Year: 2015
The role of chemokine receptors in the aberrant migration of COPD neutrophils
Source: International Congress 2014 – Cell biology 2014
Year: 2014
COPD monocytes differentiate into pro-inflammatory macrophages regardless of environment
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Platelet activating factor receptor (PAFr) expression is increased in airways of COPD patients but is not attenuated by inhaled corticosteroid (ICS)
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Elevated CCL2 responses in COPD and attenuation by selective chemokine receptor antagonists
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015
Increased susceptibility of M2 monocyte-derived macrophages from COPD patients to oxidative stress
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013
Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014
Lymphocyte senescence in COPD is associated with loss of glucocorticoid receptor expression by cytotoxic/ pro-inflammatory lymphocytes
Source: International Congress 2014 – Effect of cigarette smoke on cell behaviour: cell biology, signalling and senescence
Year: 2014
IL32 expression in induced sputum of COPD subjects
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
Up-regulation of EGFR gene family in COPD patients: Correlation with airway obstruction
Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases
Year: 2013
The effect of
in vitro
culture methods on corticosteroid sensitivity in COPD alveolar macrophages
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
IL-8 and TSLP production as markers of bronchial epithelial cell activation in IL-17A mediated airway inflammation in COPD: Role of tiotropium
Source: Annual Congress 2013 –New insights into epigenetic mechanisms in the lung
Year: 2013
Neutrophil numbers are decreased in bronchial biopsies from patients with COPD
Source: Annual Congress 2013 –COPD: new markers of diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept